Liverpool-based Applied Nutrition has announced its intention to raise up to £220 million through an IPO in London, marking a significant financial endeavour for the company.
- The IPO price range is set between 136p to 160p per share, aiming to position the company as a major player on the London Stock Exchange.
- This initiative includes an offer of up to 137.4 million shares, originating from certain current shareholders of the company.
- Four prominent entrepreneurs have committed £25 million as cornerstone investors, exemplifying strong market confidence.
- JD Sports, a key stakeholder since 2021, backs Applied Nutrition, enhancing the company’s credibility.
The Liverpool-based sports health firm, Applied Nutrition, has embarked on a landmark financial journey, seeking to raise up to £220 million from its upcoming initial public offering (IPO) on the London Stock Exchange. The company has disclosed a price range set between 136p and 160p per share, indicative of a strategic bid to bolster its market presence. This move is expected to place Applied Nutrition among the most noteworthy market entrants in London for the year.
In an ambitious manoeuvre, the IPO will see the offer of up to 137.4 million shares, predominantly held by existing shareholders. This reflects a widespread confidence in the firm’s fiscal robustness and future growth prospects. Such a substantial offering signals a notable opportunity for investors poised to capitalise on the company’s expansive strategies and market growth.
Demonstrating considerable confidence in Applied Nutrition’s potential, four distinguished North West entrepreneurs have pledged a total of £25 million as cornerstone investors. Among these is Mohsin Issa, co-founder of the EG Group, thereby highlighting a strategic alignment with influential business figures and a solid foundation of trust and reliability.
Founded in 2014 by Tom Ryder, who serves as CEO, the company has received substantial backing from JD Sports Fashion, which acquired a 32% stake in 2021. This partnership coincides with the brand’s planned US market penetration the following year, marking an era of significant strategic expansion and operational scaling.
The impending IPO brings a glimmer of hope to the London Stock Exchange, which has faced challenges with declining new listings and major companies seeking profitable returns in foreign markets. With only nine companies having floated this year, the market eagerly anticipates a resurgence, fuelled in part by reforms in listing regulations and successful floats like that of Raspberry Pi.
Applied Nutrition’s strategic IPO initiative signifies a pivotal moment for both the company and the London Stock Exchange, potentially revitalising interest in the capital’s market.
